Landaverde C - Search Results

1

Fluid retention in cirrhosis: pathophysiology and management.

Kashani A, Landaverde C, Medici V, Rossaro L. Kashani A, et al. Among authors: landaverde c. QJM. 2008 Feb;101(2):71-85. doi: 10.1093/qjmed/hcm121. Epub 2008 Jan 9. QJM. 2008. PMID: 18184668 Review.

2

De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis.

Landaverde C, Ng V, Sato A, Tabibian J, Durazo F, Busuttil R. Landaverde C, et al. Ann Hepatol. 2009 Oct-Dec;8(4):379-83. Ann Hepatol. 2009. PMID: 20009140 Free article.

3

Intraductal oncocytic papillary neoplasm of the liver: case and review of a rare variant.

Tabibian JH, Lassman CR, Margolis DJ, Landaverde C, Busuttil RW, Durazo FA. Tabibian JH, et al. Among authors: landaverde c. Ann Hepatol. 2008 Apr-Jun;7(2):168-73. Ann Hepatol. 2008. PMID: 18626437 Free article. Review.

4

The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.

Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW. Saab S, et al. Among authors: landaverde c. Exp Clin Transplant. 2006 Jun;4(1):395-9. Exp Clin Transplant. 2006. PMID: 16827633 Free article.

5

Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients.

Saab S, Ng V, Landaverde C, Lee SJ, Comulada WS, Arevalo J, Durazo F, Han SH, Younossi Z, Busuttil RW. Saab S, et al. Among authors: landaverde c. Liver Transpl. 2011 May;17(5):567-79. doi: 10.1002/lt.22267. Liver Transpl. 2011. PMID: 21506245 Free article.

6

Hepatocellular carcinoma in a hepatitis C patient with sustained viral response and no fibrosis.

Tabibian JH, Landaverde C, Winn J, Geller SA, Nissen NN. Tabibian JH, et al. Among authors: landaverde c. Ann Hepatol. 2009 Jan-Mar;8(1):64-7. Ann Hepatol. 2009. PMID: 19221537 Free article.

7

Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.

Gutierrez JA, Landaverde C, Wells JT, Poordad F. Gutierrez JA, et al. Among authors: landaverde c. Hepatology. 2016 Jul;64(1):301-2. doi: 10.1002/hep.28556. Epub 2016 Apr 15. Hepatology. 2016. PMID: 26991688 Free PMC article.

8

Deciding liver transplant candidacy: tools of the trade.

Landaverde C, Saab S. Landaverde C, et al. Liver Int. 2008 Nov;28(9):1186-9. doi: 10.1111/j.1478-3231.2008.01854.x. Liver Int. 2008. PMID: 18822075 No abstract available.

9

Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?

Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J. Berenguer M, et al. Among authors: landaverde c. Liver Transpl. 2003 Nov;9(11):1152-8. doi: 10.1053/jlts.2003.50240. Liver Transpl. 2003. PMID: 14586875 Free article.

10

Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial.

Lawitz E, Poordad F, Gutierrez JA, Wells JT, Landaverde CE, Evans B, Howe A, Huang HC, Li JJ, Hwang P, Dutko FJ, Robertson M, Wahl J, Barr E, Haber B. Lawitz E, et al. Among authors: landaverde ce. Hepatology. 2017 Feb;65(2):439-450. doi: 10.1002/hep.28877. Epub 2016 Dec 19. Hepatology. 2017. PMID: 27770561 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters